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Rebuli ME, Speen AM, Clapp PW, Jaspers I. Novel applications
for a noninvasive sampling method of the nasal mucosa. Am J Physiol
Lung Cell Mol Physiol 312: L288–L296, 2017. First published De-
cember 23, 2016; doi:10.1152/ajplung.00476.2016.—Reliable meth-
ods for sampling the nasal mucosa provide clinical researchers with
key information regarding respiratory biomarkers of exposure and
disease. For quick and noninvasive sampling of the nasal mucosa,
nasal lavage (NL) collection has been widely used as a clinical tool;
however, limitations including volume variability, sample dilution,
and storage prevent NL collection from being used in nonlaboratory
settings and analysis of low abundance biomarkers. In this study, we
optimize and validate a novel methodology using absorbent Leuko-
sorb paper cut to fit the nasal passage to extract epithelial lining fluid
(ELF) from the nasal mucosa. The ELF sampling method limits the
dilution of soluble mediators, allowing quantification of both high-
and low-abundance soluble biomarkers such as IL-1, IL-8, IL-6,
interferon gamma-induced protein 10 (IP-10), and neutrophil elastase.
Additionally, we demonstrate that this method can successfully detect
the presence of respiratory pathogens such as influenza virus and
markers of antibiotic-resistant bacteria in the nasal mucosa. Efficacy
of ELF collection by this method is not diminished in consecutive-day
sampling, and percent recovery of both recombinant IL-8 and soluble
mediators are not changed despite freezing or room temperature
storage for 24 h. Our results indicate that ELF collection using
Leukosorb paper sampling of ELF provides a sensitive, easy-to-use,
and reproducible methodology to collect concentrated amounts of
soluble biomarkers from the nasal mucosa. Moreover, the methodol-
ogy described herein improves upon the standard NL collection
method and provides researchers with a novel tool to assess changes
in nasal mucosal host defense status.
nasal mucosa; biomarkers; innate immune status; epithelial lining
fluid; storage conditions
SCIENTIFIC TECHNOLOGIES HAVE advanced throughout recent his-
tory to permit a variety of noninvasive, but extremely infor-
mative biological sample collection and analysis techniques to
be used in field research. Rapid sample collection with minimal
risk to human subjects permits more frequent sampling and
more detailed analyses throughout a time course. The devel-
opment of sample collection techniques with flexible storage
requirements also facilitates investigations in clinical and pop-
ulation studies. Dried blood spots, for example, provide a
method to detect systemic markers of inflammation, infection,
and disease (10, 16). However, an adequate method for detect-
ing respiratory inflammation or infection has not yet been
developed. Here, we describe a novel nasal mucosal sampling
method to analyze mucosal biomarkers that are suitable for use
in clinical and epidemiological studies. This method uses a
wettable, fibrous, synthetic matrix that can be stably stored at
room temperature for later analysis.
Sampling the nasal mucosa by nasal lavage (NL), or irriga-
tion of the nasal passage with isotonic saline, has emerged as
the current noninvasive standard for collection of soluble
markers in epithelial lining fluid (ELF) of the upper airways
and was optimized and validated in 2014 (17). NL has been
used extensively in peer-reviewed publications, and was pres-
ent in 2,559 instances in PubMed when “nasal lavage” was
used as a search term and 1,843 instances when “nasal lavage
and humans” was used as a search term as of August 2016. The
first mention of NL in PubMed dates to 1947 in a study by
Atlas (3). NL is less expensive to obtain and process, and much
less invasive than bronchoalveolar lavage (BAL), which is
currently used to sample the lower airways, but requires
subjects to undergo a more invasive bronchoscopy. NL collec-
tion is also less time consuming and labor intensive for the
subject and investigators than induced sputum, another tech-
nique currently used to sample the lower airways. Induced
sputum is less invasive than BAL collection (2) but involves
significant dilution of samples with saline and processing with
reducing reagents such as dithiothreitol for analysis, which can
interfere with the functionality and detection accuracy of in-
flammatory mediators in commercially available ELISA kits
(35). NL is attractive to researchers because samples can be
quickly collected and stored for long periods of time (months
to years) at 80°C for bulk analysis. However, there are
limitations to this method, including excessive sample dilution
with saline, variability in recovered NL volume between sub-
jects, potential contamination with blood during repeated ex-
pulsion of saline from the nose, and the need for freezers for
long-term storage.
Our method is an alternative to conventional NL collection
and uses Leukosorb medium (Pall Scientific, Port Washington,
NY), described by the manufacturer as an absorbent, fibrous
matrix designed for the isolation of leukocytes from whole
blood (http://www.pall.com/main/oem-materials-and-devices/
product.page?id47512). As in previous studies (9, 15, 20,
32), we use the absorbent matrix to isolate biomarkers and
soluble mediators of respiratory inflammation (i.e., cytokines,
proteases, and others) that are present at the nasal mucosal
surface. To refine the previously published technique, we
fabricated ergonomic Leukosorb strips that were designed to
easily fit within nasal passages. In addition to reliably and
reproducibly assessing levels of soluble mediators in the nasal
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mucosa, we also show that this method can successfully detect
the presence of pathogens, such as influenza virus and markers
of antibiotic-resistant bacteria, within the nasal mucosa, and
allows the strips to be stored at various conditions without
affecting mediator recovery. In addition, our method is also
easier to administer than similar studies that used a sponge in
place of Leukosorb paper (26), because a medical professional
is not needed to insert and remove the Leukosorb strips. Taken
together, the experiments described herein suggest that this
method will be effective for assessing biomarkers in the nasal
mucosa in field studies and other settings where traditional NL
is more difficult to reliably obtain or where access to freezers
for storage might be limited.
MATERIALS AND METHODS
Subject recruitment and sample collection. Healthy adult subjects
aged 22– 43 yr were recruited. The mean age of subjects was
27.2  2.3 yr (see Table 1 for demographic information), and the
median age was 24 yr. Exclusion criteria for this study included
current symptoms of allergic rhinitis, asthma, FEV1 less than 75%
predicted at screen, chronic obstructive pulmonary disorder, car-
diac disease, any chronic cardiorespiratory condition, bleeding
disorders, recent nasal surgery, immunodeficiency, tobacco use, or
current pregnancy. Subjects were recruited for a total of two visits,
the second visit being at least 24 h but not more than 2 wk from the
first visit. During visit 1, after subjects provided consent, demo-
graphic information, pregnancy tests (for women), vital signs,
nasal lavage fluid (NLF), and ELF were collected. During visit 2,
NLF and ELF were collected. The protocol was submitted to and
approved by the University of North Carolina at Chapel Hill
Biomedical Institutional Review Board.
NLF collection. NLF was obtained as described in previous studies
(19, 27–31). Briefly, nostrils were repeatedly sprayed with 0.9%
sterile, normal saline irrigation solution (a total of 4 ml per nostril) and
expelled into collection cups. The cellular component was then
isolated from the NLF using filtration (40 m cell strainer) and
centrifugation as described previously (19, 27–31). Cell-free NLF and
NLF cells were then stored at 80°C until analysis.
ELF collection on Leukosorb strips. Strips were cut from sheets of
Leukosorb medium using a laser cutter to the dimensions shown in
Fig. 1, B and C. Strips and their respective 1.5-ml microcentrifuge
containers were preweighed. Strips were removed from their tubes
and inserted into the anterior part of the inferior nasal turbinate of
each nostril. Before the strips were inserted, each nostril was briefly
moistened with ~100 l of 0.9% sterile, normal saline solution.
Leukosorb strips were then inserted into each nostril until the indica-
tor mark was at or close to the base of each nare. After insertion,
nostrils were clamped shut using a padded nose clip for 2 min. Strips
were then removed from the nostril and collected in their respective
1.5-ml collection tubes, and again weighed and stored at 20°C,
unless evaluating storage conditions, until ELF elution.
Evaluating percent recovery of protein from Leukosorb strips.
Varying known amounts of IL-8 recombinant protein (PeproTech,
Rocky Hill, NJ) suspended in double-deionized H2O (100 l total
volume) was applied to strips of Leukosorb paper and allowed to
absorb. The strips were then stored in one of four storage conditions
[immediate elution, 20°C, room temperature (21  2°C), or 37°C]
for 24 h. Strips were then eluted and analyzed via ELISA (see
flowchart, Fig. 1A).
Evaluating variability. Variability within (nare to nare and day to
day) and between subjects was evaluated by collecting strips from
both nares of subjects on 3 consecutive days and storing them at
20°C until elution and analysis via ELISA (Fig. 2).
Evaluating storage conditions. The Leukosorb strips were stored in
four different storage conditions (20°C, room temperature
(21  2°C), immediate elution, and 37°C) according to the flowchart
in Fig. 3A after collection. The two strips collected at each visit were
randomized to either protocol A or protocol B for visit 1 and stored in
the alternate protocol for visit 2. For the storage conditions at room
temperature or 37°C, strips were removed from their 1.5-ml tube and
Table 1. Subject demographics
Descriptor Value
Body mass index 24.5  0.7
Age, yr 27.2  2.3
Sex, female/male 4/6
Race/ethnicity, White/African American/Asian 8/1/1
Body mass index and age are presented as means  SE, n  10.
Fig. 1. Percent recovery of recombinant IL-8
from Leukosorb strips using various storage
conditions. A: flowchart describing methods
for detecting the percent recovery of IL-8
recombinant protein from Leukosorb strips.
B: image of a Leukosorb strip and its relative
size. C: diagram and measurements of cut
Leukosorb strips. D: percent recovery of
recombinant IL-8 from Leukosorb strips at
varying storage conditions (n 5). A known
amount of recombinant IL-8 with no carrier
was spiked onto Leukosorb strips. The strips
were then stored in triplicate in four storage
conditions (immediate elution,20°C, room
temperature, or 37°C). Protein was then
eluted from strips and the eluant was stored
at 20°C until analysis (at least 24 h). The
strips were then batch-analyzed by ELISA
and compared with protein of a known con-
centration. Compared with the strips that
were immediately eluted, there was a signif-
icant difference in percent recovery only in
the 37°C group. Values are presented as
means  SE. *P  0.05.
L289APPLICATIONS FOR ELF SAMPLING METHOD OF THE NASAL MUCOSA
AJP-Lung Cell Mol Physiol • doi:10.1152/ajplung.00476.2016 • www.ajplung.org
Downloaded from www.physiology.org/journal/ajplung at Univ of North Carolina Chapel Hill (152.002.071.053) on August 12, 2019.
placed in covered Petri dishes (Nalge Nunc International, Rochester,
NY) in either a vented storage container at room temperature or in a
heated incubator (Innova 4000; New Brunswick Scientific, Edison,
NJ) for 24 h. After the 24-h period, the strips at room temperature and
37°C (both conditions yielded completely dried strips) were returned
to their 1.5-ml tube for subsequent elution.
ELF elution from Leukosorb strips. For ELF elution, strips were
placed in 650-l microcentrifuge tubes, which were modified with an
18-gauge needle to have a hole at the tip of the tube. Tubes containing
the strips were placed in a 1.5-ml microcentrifuge tube and 100 l of
a 1% BSA  0.05% Triton X-100 in Dulbecco’s PBS (GIBCO/
Thermo Fischer, Waltham, MD) was added to the strip. Strips were
centrifuged twice at 13,000 revolutions per minute for 2 min to elute
the ELF from the strip into the 1.5-ml tube. The ELF was then stored
at 20°C until analysis.
ELISA of biomarkers of immunological status. Cell-free NLF and
ELF were used to analyze IL-8, IL-6, IL-1, interferon -induced protein
10 (IP-10), and neutrophil elastase via commercially available ELISA
kits (BD OptEIA, Franklin Lakes, NJ for IL-8, IL-6, IP-10, and IL-1;
eBioscience Human PMN-Elastase Platinum ELISA, San Diego, CA, for
neutrophil elastase) (see Figs. 1–4). Absorbance was measured using a
CLARIOstar microplate reader (BMG Labtech, Ortenberg, Germany).
Detection of pathogens. Subjects were given a standard dose of live
attenuated influenza virus (LAIV) vaccine (MedImmune Astra
Zeneca, Gaithersburg, MD) in both nostrils to simulate an influenza
virus infection, which allowed us to assess a controlled disease
population mimic. ELF and NLF samples were collected before
exposure (day 0) and 1 day (day 1) after LAIV exposure. The
schematic of experimental design is summarized in Fig. 5A. ELF and
cells isolated from NLF were subjected to further analysis. Informed
consent was obtained from all subjects, and the protocol was submit-
ted to and approved by the University of North Carolina at Chapel Hill
Biomedical Institutional Review Board.
Total RNA was isolated from the Leukosorb strips using the Pure Link
RNA Mini Kit (Life Technologies, Carlsbad, CA) by submerging the strips
in 300 l of Pure Link RNA Mini Kit Lysis Buffer for 15 min, vortexed
every 5 min, and collecting the eluate through centrifugation as described
above. First-strand cDNA preparation and real-time quantitative PCR
(qPCR) were performed as previously described (1, 2) using the following
primer/probe pairs specific for the M1 gene of the LAIV Influenza B Ann
Arbor/1/66 master donor strain: 5=-FAM-CCCTCTTGTTGTTGCCGC-
TAMRA-3= (probe), 5=-GGGTGCAGATGCAACGATT-3= (sense), and
5=-AATATCAAGTGCAAGATCCCAATG-3= (antisense); and for the me-
thicillin-resistance (mecA) gene commonly found in antibiotic-resistant bac-
teria, such as Staphylococcus aureus: 5=-FAM-AGATCTTATGCAAACT-
TAATTGGCAAATCC-TAMRA-3= (probe), 5=-GGCAATATTACCG-
CACCTCA-3= (sense), and 5=-GTCTGCCACTTTCTCCTTGT-3=
(antisense). Differences in expression were determined using the 		Ct
method and -actin mRNA expression for normalization (21, 22).
Statistical analysis. Prism 6 software (GraphPad, La Jolla, CA) was
used to visualize and analyze all data sets. A paired t-test was used to test
for an effect of nare, day, and the difference between ELF and NLF. A
repeated-measures one-way ANOVA was used to test for an effect of
day, storage condition, or interindividual variability. A Dunnett’s test was
used for post hoc testing to compare all groups with the immediate elution
group. A value of P 
 0.05 was considered significant.
RESULTS
Percent recovery of recombinant protein from Leukosorb
paper. Recovery of recombinant IL-8 for all four storage
conditions (see flowchart, Fig. 1A) was found to be
Fig. 2. Intranare, day-to-day, and interindividual variability of IL-8 production in epithelial lining fluid (ELF). A: flowchart describing methods for determining
variability in ELF samples within nares, from day to day, and between individuals using Leukosorb paper and IL-8 ELISA. B: intranare variability in IL-8
production using the average of the right nare over 3 days of sampling and left nare over 3 days of sampling (biological replicates  3). There was no significant
difference in IL-8 concentration intranare. Means are graphed for each individual. C: day-to-day variability in IL-8 production. The left and right nare were
averaged for each day for a biological replicate of two. There was no significant variability in IL-8 concentration over the 3 days. Means are graphed for each
individual at each day. D: interindividual variability in IL-8 production. Right and left nare measurements for each of the 3 days is graphed for each individual.
There is significant interindividual variability. There is also a significant sex difference, IL-8 production is greater in men than it is in women. Values are
presented as means  SE. In B–D, n  5; open squares indicate men, closed circles indicate women. ***P  0.001.
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Fig. 3. Effectiveness of a variety of storage
conditions for collection and analysis of ELF
for biomarkers of immune status from Leu-
kosorb strips. A: flowchart describing meth-
ods for determining the effectiveness of
varying storage conditions on analysis of
ELF from Leukosorb strips for biomarkers
of immune status. B: IL-1 collected per
strip. Levels were lower in the 37°C group
than in the immediate-elution group. C: IL-6
collected per strip. D: IL-8 collected per
strip. Levels were lower in the 37°C group
than the immediate-elution group. E: IP-10
collected per strip. F: neutrophil elastase
collected per strip. Groups of strips stored at
room temperature (RT) and 37°C had lower
values of neutrophil elastase than the group
that underwent immediate elution. G: IL-8
concentration resultant from elution of Leu-
kosorb strips. The groups stored at RT and
37°C were dried out during storage. They
were thus eluted in a lower volume of liquid,
making the resultant protein more concen-
trated. The concentration of the eluant per
milliliter is shown. The eluent at room tem-
perature was more concentrated than the
group that underwent immediate elution
(Immed. Elution) and thus would be better
for detecting low-abundant protein than the
more dilute eluant of the immediate-elution
group. Values are presented as means  SE.
In B–G, n  10. Statistical analysis included
one-way ANOVA with a Dunnett’s post hoc
test, comparing all groups with the immedi-
ate-elution group. *P 0.05, ***P 0.001.
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94.8  11.9% at immediate elution, 69.3  10.6% at 20°C,
83.9  5.2% at room temperature, and 57.1  3.2% at 37°C.
There was a statistical difference only between the immediate
elution and 37°C groups (Fig. 1D).
Intranare, day-to-day, and interindividual variability. Intra-
nare, day-to-day, and interindividual variability was assessed
using methods summarized in the flowchart in Fig. 2A. There
was no statistical difference between nares (Fig. 2B) or day-
to-day (Fig. 2C), however, there was a significant interindi-
vidual variability (Fig. 2D).
Evaluating storage conditions. Leukosorb strips were col-
lected and stored as summarized in Fig. 3A. Figure 3, B–F
shows the amount of each cytokine, chemokine, or protease
recovered per strip. There were no significant differences
between groups for cytokines and chemokines compared with
the immediate-elution group, except IL-1 and IL-8 at 37°C
(Fig. 3, B–E). There was a significant difference in neutrophil
elastase between the room-temperature and 37°C groups com-
pared with the immediate-elution group (Fig. 3F). The volume
of eluant recovered from the groups varied; ~200 l was
recovered from the immediate-elution and 20°C groups, and
100 l was recovered from the room-temperature and 37°C
groups. This difference resulted from the strips at room tem-
perature and 37°C drying out during the 24 h of storage, during
Fig. 4. Comparison of ELF from Leukosorb strips and
traditional nasal lavage fluid (NLF) for detection of biomark-
ers of immune status. The immediate-elution group from the
ELF storage condition study was compared with visit 1 (v1)
NLF from the same subjects. A: IL-1 levels in ELF vs.
NLF. Significantly more IL-1 was detected in the ELF than
the NLF. B: IL-6 levels in ELF vs. NLF. C: IL-8 levels in
ELF vs. NLF. Significantly more IL-8 was detected in ELF
than in NLF. In addition, there was a significant sex differ-
ence in the immediate-elution group, in which IL-8 levels
were higher in men than in women. D: IP-10 levels in ELF
vs. NLF. Significantly more IP-10 was detected in ELF than
in NLF. E: neutrophil elastase (NE) levels in ELF vs. NLF.
Significantly more NE was detected in ELF than NLF. In
addition, there was a significant sex difference in the imme-
diate elution group, in which NE levels were higher in men
than in women. F: day-to-day variability in IL-8 NLF. NLF
from the 2 days of collection were compared, and there was
no variability detected between the 2 days; n  10; v2 indi-
cates visit 2. Statistical analysis included a paired t-test
comparing ELF with NLF. Sex difference was detected using
a two-way ANOVA with sex and storage condition as factors
with a Dunnett’s post hoc test comparing all groups with the
immediate elution group. *P  0.05, ***P  0.001.
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which all moisture was removed from the strip, whereas the
immediate-elution and 20°C groups retained moisture of the
mucous from the nasal passage in addition to the volume of
buffer used to elute immune mediators from the strips. The
eluant from strips maintained at room temperature and 37°C
was therefore twice as concentrated as that in the immediate-
elution and 20°C groups, which is reflected in the eluant
concentration depicted in Fig. 3G. This resulted in IL-8 con-
centrations within the room-temperature group being signifi-
cantly greater than the immediate-elution group when consid-
ering the concentration of the eluant (Fig. 3G) rather than the
amount of mediator recovered from each strip (Fig. 3, A–F).
ELF vs. NLF comparison. ELF from Leukosorb strips pro-
vided significantly more concentrated mediators compared
with traditional NLF collection for all mediators analyzed
except IL-6 (Fig. 4, A–E). There was no day-to-day variability
in NLF (Fig. 4F), therefore, all comparisons were made be-
tween the immediate-elution group from Leukosorb paper and
visit 1 NLF.
In addition to a significant difference between ELF and
NLF, sex differences in IL-8 and neutrophil elastase were
detected in the immediate-elution group. IL-8 levels were
significantly higher in men than in women (significant main
effect of storage condition, sex, and their interaction) (Fig. 4C).
Neutrophil elastase levels were also higher in men than in
women (significant main effect of storage condition and sex)
(Fig. 4E).
Detection of pathogens. To determine whether the presence
of viral and bacterial RNA from potential diseased populations
is measurable, we used the ELF sampling method to retrieve
samples from healthy volunteers inoculated with LAIV,
thereby mimicking a diseased population in a controlled fash-
ion. We then analyzed the samples for expression of influenza
B and mecA, a gene associated with antibiotic-resistant bacte-
ria. Viral and bacterial RNA content was assessed in matched
samples acquired using the ELF sampling method and the
standard NLF collection method. As expected, minimal to no
viral RNA was detectable before LAIV administration on day
0. At day 1 after administration, virus was detectable in all ELF
samples and NLF cell samples (Fig. 5B). Bacterial RNA was
detected in ELF samples from two subjects, regardless of
sampling day, but could not be detected in NLF cells (Fig. 5C).
DISCUSSION
The goal of this study was to develop a rapid, noninvasive
method for the collection and storage of ELF from the nasal
passages of human subjects that would be comparable to ease
of collection and storage of dried blood spots. The use of
Leukosorb paper to evaluate soluble mediators in the nasal
mucosa was previously described, when two types of absorp-
tive matrices, Accuwik Ultra and Leukosorb, were used to
recover cytokines and evaluate percent protein recovery (14,
20). Accuwik Ultra has been previously compared with other
matrices and shown to be adequate for isolation of cytokines,
but it is no longer available, and Leukosorb was suggested as
an adequate alternative (14, 20, 32). Other matrices of similar
quality may be available but were not tested in this study. We
show that cytokines, chemokines, and proteases can be reliably
recovered from Leukosorb paper that was frozen, dried at room
temperature, or dried at 37°C for 24 h. This method (ELF) also
provides more concentrated samples and subsequent increased
sensitivity of biomarker analysis, especially when dried at
room temperature, than NLF (several orders of magnitude
times more concentrated, depending on the mediator), suggest-
ing that difficult-to-measure respiratory biomarkers could be
assessed using this strategy. Moreover, our data indicate that
Leukosorb strips can be used to assess the presence of respi-
ratory pathogens such as influenza and bacteria, thus providing
a reliable and noninvasive method to assess markers of im-
mune status in the nasal mucosa of human volunteers.
The results of our study illustrate the day-to-day repro-
ducibility, intranare similarities, and expected interindi-
vidual variability in nasal mucosal mediator levels. There is
no statistically significant day-to-day or intranare variabil-
ity, suggesting that repeated sampling over multiple days
can be used with little to no irritation of the nasal epithelium
(Fig. 2). The consistency of day-to-day and intranare mea-
Fig. 5. Ability of ELF to measure viral markers of disease in
subjects given the live attenuated influenza virus (LAIV) vac-
cine and the presence of bacteria. A: flowchart describing
methods for administration of LAIV to healthy volunteers. B:
measurement of influenza FluB gene expression before LAIV
administration (day 0) and 1 day after exposure (day 1) from
samples collected through both ELF and NLF sampling meth-
ods. C: measurement of gene expression of the antibiotic-
resistant bacteria marker mecA before and after LAIV in ELF
and NLF samples; n  6.
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sures does not mitigate the ability to detect interindividual
variability (Fig. 2C). In fact, the concentration of ELF
samples permits increased detection sensitivity for differ-
ences between individuals, treatments, exposures, etc. In-
creased detection sensitivity is further demonstrated by our
ability to reproducibly detect inflammatory mediators of low
abundance (IL-1), medium abundance (IL-6 and IP-10),
and high abundance (IL-8), as well as protease (neutrophil
elastase) in the nasal mucosa of healthy individuals. In
contrast, IL-1 and IL-6 were at the lower limits of detec-
tion in NL samples (Fig. 4). Considering that variability of
mediator measurements increases at the lower limit of
detection, interindividual differences will likely be more
detectable using the ELF methodology and potentially re-
veal differences between different study groups that were
previously undetected. For example, the observation that
there is a sex difference in baseline nasal mucosal IL-8
levels has not been previously reported. Here we report that
nasal IL-8 levels were significantly higher in men than in
women and there was a significant effect of sex in baseline
neutrophil elastase in the immediate elution group, in which
men had a higher amount of neutrophil elastase than women
(Fig. 2D). Increased levels of both IL-8 and neutrophil
elastase suggest a possible increased prevalence of neutro-
phils or improved ability to prime neutrophils to respond to
infection (36, 37) in the nasal mucosa of men compared with
women. The enhanced ability to detect this baseline sex
difference may be due to the reduced variability in recovery
volume of the ELF methodology (100 –200 l) compared
with the highly variable recovery volume of NLF (2– 6 ml),
as well as an increased concentration of mediators within
the eluate. However, because the sample size was small and
the results may have been influenced by other outside/
clinical factors such as occupational toxicant exposure, rural
vs. urban habitation, recreational drug use, etc., such con-
clusions are limited and should be further investigated in
future studies.
Additionally, the increased concentration and recovery of
cytokines and chemokines from Leukosorb paper does not
dissipate when strips are stored at room temperature for 24
h (Fig. 3, A–E). In fact, drying strips further concentrates the
soluble mediators in the ELF, making it possible to detect
low-abundance mediators (Fig. 3G). Some degradation of
neutrophil elastase occurred in the room-temperature and
37°C groups (Fig. 3F), and some degradation of IL-1 and
IL-8 occurred in the 37°C group; however, all groups that
exhibited some degradation were still within the limits of
detection and of greater abundance in the ELF than the NLF
tested. An additional benefit to drying strips can be inferred
from the dried blood spot literature, in which it has been
demonstrated that drying samples can damage viral caspids
(6, 33), thus reducing the potential for contamination of
laboratory staff who process the samples without compro-
mising the ability to detect virus in analysis (6, 33). It also
permits samples to be shipped via mail with little to no risk
to the general public (24). Hence, the use of Leukosorb
strips is not limited to storage in refrigerated or frozen
conditions, making this method advantageous for nasal
biomarker collection studies conducted outside a laboratory
setting.
Although our study was limited to 24 h of storage at room
temperature, other studies have indicated that many mucosal
mediators are stable for more extended periods at temperatures
higher than 80°C and over at least one freeze-thaw cycle (4,
11). Studies using dried blood spots have also shown that the
stability of proteins varies depending on the protein; however,
generally, most proteins are stable at room temperature up to 1
wk (7). The literature (25) also suggests that drying cytokines
reduces molecular mobility, thereby delaying degradation for a
more extended period than if they were in solution. Specific
degradation timelines for cytokines or other proteins of interest
should be validated before using this method in future studies,
because a limited number of cytokines and only one time point
were investigated here. Our study was also limited by the
relatively small sample size, and the results of this study should
be interpreted as proof of principle and should be further
validated with a larger cohort for use in clinical studies.
Therefore, for nonlaboratory setting studies, the use of Leuko-
sorb strips to collect nasal mucosal mediators and the ability to
store samples at room temperature would present a novel,
noninvasive, and reproducible methodology to determine re-
spiratory biomarkers of infection or inflammation.
In addition to quantitatively assessing soluble mediators,
ELF collected on Leukosorb strips can also be used to
determine the presence of respiratory pathogens such as
influenza virus and antibiotic-resistant bacteria, such S.
aureus, thus making it a potentially valuable method for
assessing diseases within a given population and studying
the airway microbiome. Leukosorb strips obtained from
subjects before and after administration of LAIV (a well-
controlled diseased population mimic because it replicates
only in the upper airway) tested positive for viral RNA on
the day following LAIV vaccine (Fig. 5B) (28). Notably, the
samples obtained using the ELF collection method yielded
similar RNA levels compared with NLF cell collection,
highlighting the fact that ELF allows measurement of shed
virus particles present in the nasal mucosa. These samples
were also used to detect the presence of the mecA gene,
which is commonly associated with antibiotic-resistant S.
aureus, a pathogen known to colonize the nasal passages in
~80% of the population (20 –30% being permanent carriers
and 60% intermittent) (8, 23). Two out of the six ELF
samples tested positive for mecA expression, which is within
the range of antibiotic-resistant S. aureus found in epidemi-
ological studies (1, 12, 13, 18), whereas none were detect-
able in NLF cells (Fig. 5C). Assessing the nasal mucosa for
respiratory pathogens has clinical relevance because the
nose is the predominant entry point for many respiratory
pathogens, including viruses and bacteria (5), demonstrating
that the ELF method can be used to assess immune status or
the presence of pathogens in diseased populations. The
ability to detect bacterial genes from ELF also suggests that
ELF could be used to assess the microbiome and potentially
the mycobiome. As such, local changes of inflammatory
mediators and microbiota and mycobiota within the nasal
mucosa may be evaluated similarly to our method as early
indicators of disease (34).
In conclusion, Leukosorb sampling of nasal ELF may be a
reliable and reproducible method to assess biomarkers of
innate immune status in the airway that results in more con-
centrated and less variable sample of the nasal mucosa than
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with traditional NL. Furthermore, this method may aid in the
detection of pathogens such as influenza virus and antibiotic-
resistant bacteria within the nasal mucosa. Validation of the
novel ELF collection method also suggests that samples can be
stored in a variety of conditions without compromising sample
quality and biomarker detectability. Taken together, these data
indicate that ELF collected via Leukosorb strip is effective in
assessing nasal mucosal biomarkers of innate immune status
and will be useful in both field studies and in populations in
which traditional NL is more difficult to reliably obtain and
store.
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